Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ayon Nandi

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Translational Psychiatry|September 14, 2021
Positron emission tomography imaging of serotonin degeneration and beta-amyloid deposition in late-life depression evaluated with multi-modal partial least squaresGwenn S Smith, Clifford I Workman, Hillary Protas, et al.
Neuroimage. Clinical|January 21, 2023
Molecular imaging of the association between serotonin degeneration and beta-amyloid deposition in mild cognitive impairmentGwenn S Smith, Hillary Protas, Hiroto Kuwabara, et al.
Molecular Imaging and Biology|August 23, 2014
Human brain imaging of α7 nAChR with [(18)F]ASEM: a new PET radiotracer for neuropsychiatry and determination of drug occupancyDean F Wong, Hiroto Kuwabara, Martin Pomper, et al.
Neuroimage|April 22, 2010
Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMARDean F Wong, Hiroto Kuwabara, Andrew G Horti, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 8, 2007
Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PETDean F Wong, James R Brasić, Harvey S Singer, et al.
Synapse (New York, N.Y.)|January 14, 2009
Single photon emission computed tomography experience with (S)-5-[(123)I]iodo-3-(2-azetidinylmethoxy)pyridine in the living human brain of smokers and nonsmokersJames Robert Brasić, Yun Zhou, John L Musachio, et al.
Journal of Alzheimer'S Disease : JAD|September 18, 2023
Serotonin Degeneration and Amyloid-β Deposition in Mild Cognitive Impairment: Relationship to Cognitive DeficitsGwenn S Smith, Hiroto Kuwabara, Haijuan Yan, et al.
Brain Sciences|December 1, 2020
Reduced Expression of Cerebral Metabotropic Glutamate Receptor Subtype 5 in Men with Fragile X SyndromeJames R Brašić, Ayon Nandi, David S Russell, et al.
Brain Sciences|March 25, 2022
Fragile X Mental Retardation Protein and Cerebral Expression of Metabotropic Glutamate Receptor Subtype 5 in Men with Fragile X Syndrome: A Pilot StudyJames Robert Brašić, Jack Alexander Goodman, Ayon Nandi, et al.
Neurobiology of Aging|February 16, 2021
Molecular imaging of beta-amyloid deposition in late-life depressionGwenn S Smith, Hiroto Kuwabara, Ayon Nandi, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Translational Psychiatry|September 14, 2021
Positron emission tomography imaging of serotonin degeneration and beta-amyloid deposition in late-life depression evaluated with multi-modal partial least squaresGwenn S Smith, Clifford I Workman, Hillary Protas, et al.
Neuroimage. Clinical|January 21, 2023
Molecular imaging of the association between serotonin degeneration and beta-amyloid deposition in mild cognitive impairmentGwenn S Smith, Hillary Protas, Hiroto Kuwabara, et al.
Molecular Imaging and Biology|August 23, 2014
Human brain imaging of α7 nAChR with [(18)F]ASEM: a new PET radiotracer for neuropsychiatry and determination of drug occupancyDean F Wong, Hiroto Kuwabara, Martin Pomper, et al.
Neuroimage|April 22, 2010
Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMARDean F Wong, Hiroto Kuwabara, Andrew G Horti, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 8, 2007
Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PETDean F Wong, James R Brasić, Harvey S Singer, et al.
Synapse (New York, N.Y.)|January 14, 2009
Single photon emission computed tomography experience with (S)-5-[(123)I]iodo-3-(2-azetidinylmethoxy)pyridine in the living human brain of smokers and nonsmokersJames Robert Brasić, Yun Zhou, John L Musachio, et al.
Journal of Alzheimer'S Disease : JAD|September 18, 2023
Serotonin Degeneration and Amyloid-β Deposition in Mild Cognitive Impairment: Relationship to Cognitive DeficitsGwenn S Smith, Hiroto Kuwabara, Haijuan Yan, et al.
Brain Sciences|December 1, 2020
Reduced Expression of Cerebral Metabotropic Glutamate Receptor Subtype 5 in Men with Fragile X SyndromeJames R Brašić, Ayon Nandi, David S Russell, et al.
Brain Sciences|March 25, 2022
Fragile X Mental Retardation Protein and Cerebral Expression of Metabotropic Glutamate Receptor Subtype 5 in Men with Fragile X Syndrome: A Pilot StudyJames Robert Brašić, Jack Alexander Goodman, Ayon Nandi, et al.
Neurobiology of Aging|February 16, 2021
Molecular imaging of beta-amyloid deposition in late-life depressionGwenn S Smith, Hiroto Kuwabara, Ayon Nandi, et al.
Pageof 3